Vigilant appoints new VP of commercialization

DrBicuspid.com staff writers
Oct 4, 2015

Vigilant Biosciences has announced the appointment of James McMenamy as vice president of commercialization.

McMenamy will lead the company's strategic marketing efforts globally as it continues to advance its OncAlert oral cancer risk assessment system toward commercialization, according to Vigilant.

McMenamy most recently served as the vice president of business and product development at SCIL Animal Care, which was recently acquired by Henry Schein.

Latest in Oral Cancer
Bill Brodie
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
April 18, 2024
Researcher
Nanoparticles to be developed to treat oral cancer
April 1, 2024
Do you have patients who can’t or simply won’t floss?
Sponsored
Do you have patients who can’t or simply won’t floss?
February 2, 2024
Cancer Cell
Oral cancer detection with a stroke of a brush?
January 30, 2024
Related Stories
2014 06 19 10 46 55 930 Laser Red Beams 200
Oral Cancer
Can a laser detect oral cancer?
2014 08 25 16 33 23 1 Hpv Virus Nih 200
Oral Cancer
HPV vaccine could eliminate recurrent oral papillomas
2013 09 03 14 41 25 490 Hpv 200
Oral Cancer
Study: Oral rinse may predict return of HPV-related OPC
Do you have patients who can’t or simply won’t floss?
Sponsor Content
Do you have patients who can’t or simply won’t floss?
More in Oral Cancer
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
By Kevin Henry
As Oral Cancer Awareness Month continues, we take a look at a company that is using biomarkers as a way to catch oral cancer earlier and give patients a better chance of survival.
April 18, 2024
Bill Brodie
Nanoparticles to be developed to treat oral cancer
By Ava Barros
A lipid nanoparticles platform may treat oral squamous cell carcinoma by changing the genetic material of lymph nodes, according to research presented at the International Association for Dental, Oral, and Craniofacial Research.
April 1, 2024
Researcher
New test may be better way to detect oral cancer
By Ava Barros
A new test may detect a germ-fighting protein associated with oral cancer, track precancerous lesions, and determine when a biopsy is necessary. The study was recently published in Cell Reports Medicine.
March 26, 2024
Dr. Aaron Weinberg, PhD. Image courtesy of Case Western University.
Oral cancer detection with a stroke of a brush?
By Ava Barros
Researchers at the University of Illinois at Chicago College of Dentistry have created a diagnostic test kit that detects oral cancer early with a brush biopsy that can be done in a dental office, according to an article published by the university.
January 30, 2024
Cancer Cell
It’s not cheesy. An antimicrobial may treat oral cancer.
By Ava Barros
Researchers are conducting a clinical trial to determine whether an antimicrobial food additive found in cheese may be used to treat oral cell carcinoma, according to the University of California, Los Angeles School of Dentistry.
January 29, 2024
Bacteria Microscope
This numbing agent may kill HNC cells
By Ava Barros
The common dental numbing agent lidocaine triggers specific bitter taste receptors in the mouth that may ultimately lead to the death of head and neck cancer cells, according to a preclinical study recently published in Cell Reports.
December 5, 2023
Anesthetic Needle Vials
Young users of e-cigarettes more likely to report chronic stress
By Amerigo Allegretto
Young people who vape are more than twice as likely to report experiencing chronic stress.
October 3, 2023
Vaping Teenager
'Gates of heaven' calcium channel may drive oral cancer growth, pain
By Will Morton
New York University researchers suggest that ORAI1 calcium channel activity in oral cancer cells could be targeted to reduce the growth of oral tumors and reduce pain, according to a study that was recently published in Science Signaling.
September 12, 2023
Cell Gene Therapy Dna
MUSC researchers developing oral cancer vaccine
By Amerigo Allegretto
Researchers from the Medical University of South Carolina (MUSC) are developing a new type of personalized vaccine to prevent recurrences of oral cancer.
September 7, 2023
Researcher
Researchers awarded grant to study radiation therapy delays
By Amerigo Allegretto
Researchers from South Carolina have been awarded a $3.5 million grant to reduce delays in radiation therapy for head and neck cancers.
August 28, 2023
Radiation Therapy
Raising awareness of oral cancer through patient communication
By Misty Mattingly, RDH
With increasing rates of oral cancer, it’s time to re-examine our approach to informing patients about the risks, writes Misty Mattingly, RDH.
August 24, 2023
Misty Mattingly, RDH.
High oral HPV burden puts older men at risk of oropharyngeal cancer
By Kate Madden Yee
Older men carry the highest burden of oral HPV, putting them at the greatest of oropharyngeal cancer.
August 22, 2023
Male Patient Dental Chair
Page 1 of 115
Next Page